Rheumatoid arthritis affects women more often than men, but the reason is not fully explained. This paper adds an important molecular clue: an X-chromosome-linked microRNA may help drive stronger inflammatory immune responses.
The study focuses on miR-542-5p. The researchers found that this microRNA was increased in RA patients and showed gender-related differences. In animal models, female
rats developed more severe arthritis than male rats, along with stronger immune responses and higher miR-542-5p levels. Further experiments showed that miR-542-5p promotes the differentiation of Th17 cells.
This matters because Th17 cells are important drivers of autoimmune inflammation. When Th17 activity becomes too strong, the immune system can become more aggressive toward the body’s own tissues. In RA, this can contribute to joint inflammation, swelling, and tissue damage.
The novelty of this paper is that it connects sex biology with immune tolerance. It suggests that RA is not only shaped by general inflammation, but also by sex-linked regulation of T-cell behavior. This may help explain why female patients are more affected and why future RA care may need to consider sex-specific immune pathways.
For the cluster topic of immune tolerance, the paper shows that tolerance is not the same in every body. Biological sex may influence how easily the immune system shifts from protection to self-attack. miR-542-5p therefore becomes a possible biomarker or therapeutic target for more personalized RA management.
References
J. J. Yang et al., “X-chromosome-linked miR-542-5p as a key regulator of sex disparity in rats with adjuvant-induced arthritis by promoting Th17 differentiation,” Biomarker Research, vol. 13, article 36, 2025. Doi: 10.1186/s40364-025-00741-x
